Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers Gobburu JV, Agers H, Jusko WJ, Ynddal L Pharmaceutical Research (1999) This PK/PD study in human volunteers documented Ipamorelin's pharmacokinetic profile, showing peak GH concentrations approximately 30-40 minutes post-injection with effects lasting 2-3 hours
As a food supplement, do not exceed the recommended daily dose
The limited absorption of the nasal cavity restricts the amount of drug being effectively absorbed, making class I drugs (high permeability, high solubility), according to the Biopharmaceutics Drug Disposition Classification System (BDDCS), particularly suitable for nasal delivery (Ugwoke et al., 2001)
B.RamachandranA.LemastersJ
Li Y, Eitan S, Wu J, Evans CJ, Kieffer B, Sun X, Polakiewicz RD (2003) Morphine induces desensitization of insulin receptor signaling
[DOI] [PubMed] [Google Scholar] 114.Cooper A.J.L., Hanigan M.H